Health News Releases

  • Today February 19
September 11, 2015 18:50
Merck and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015
Merck and Pfizer today announced that six abstracts on studies evaluating the potential role of programmed death-ligand 1 (PD-L1) inhibition and the safety and efficacy of the investigational cancer i
September 10, 2015 12:00
U.S. FDA Grants Priority Review to Takeda’s Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502, http://goo.gl/eX9kbP) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review status to the New Drug Application
September 09, 2015 17:55
Jean Boulle Group - US$250 Million+ Abbott Laboratories Acquisition of Tendyne Holdings Mitral Valve Company Confirms the Group’s Pedigree for Making Serial Major Discoveries from Mines to Medical technology.
Jean Boulle Medtech Ltd, a Jean Boulle Group (www.jeanboullegroup.com) medical technology company and founding investor of Tendyne Holdings, Inc. (“Tendyne”), is pleased to announce that Abbott Labora
September 09, 2015 11:00
AstraZeneca Presents Further Evidence for the Potential of AZD9291 in First-Line and Pre-Treated Non-Small Cell Lung Cancer
AstraZeneca today announced updated data on AZD9291 in first-line patients with epidermal growth factor receptor mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC) and previously-tr
September 08, 2015 22:00
Major Innovation in Poultry Vaccines: Merial Avinew™ NeO Effervescent Tablet Advances Vaccine Delivery
Merial, the animal health division of Sanofi, today announced the global launch of a significant innovation in poultry vaccination technology: an effervescent tablet vaccine for the prevention of Newc
September 08, 2015 17:50
Boehringer Ingelheim: New Data Show That More Than 50% of Patients and Carers Struggled to Cope with Challenges of Living with Lung Cancer
The Global Lung Cancer Coalition (GLCC) presented, at the 16th World Conference on Lung Cancer (WCLC) in Denver, USA, results of Lung Cancer: We’re Listening, a global campaign, supported by Boehringe
September 07, 2015 17:40
ReSound® Returns to International Consumer Electronics Show to Feature Expanded Portfolio of Smart Hearing Aids
ReSound is pleased to announce today that it has returned to IFA, the world’s largest international consumer electronics show, in Berlin, Germany, to showcase the company’s expanding portfolio of awar
September 06, 2015 21:05
Very Low Nicotine Cigarettes: A Game-Changer for the Tobacco Industry
22nd Century Group, Inc. (NYSE MKT:XXII)(http://goo.gl/7CavNZ), a world-leader in tobacco harm reduction, announced today that the Company has launched a new website, www.magiccigarettes.com, for its
September 04, 2015 13:20
GN ReSound Opens Johor Malaysia Factory and Distribution Center to Support Continued Company Growth
Today, GN ReSound®, a global leader in innovative hearing technologies, hosted an official opening ceremony for the company’s newest manufacturing and distribution facility in Kulaijaya, Johor, Malays
August 31, 2015 09:30
ESC launches new concept for driving innovation in cardiovascular research with exclusive support from Boehringer Ingelheim
The European Society of Cardiology (ESC) today announced the launch of the competitive medical research programme ‘ESC Grants for Medical Research Innovation’, exclusively supported by an independent
August 28, 2015 09:00
Asia's Largest Business Partnering Event - Biotech Industry Key Players from 30 Countries to Gather at BioJapan 2015!
BioJapan 2015 will be held for three days from October 14th (Wed) to 16th (Fri), 2015 at Pacifico Yokohama. This Smart News Release features multimedia. View the full release here: http://www.busin
August 26, 2015 21:30
Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer
Adare Pharmaceuticals, Inc., formerly Aptalis Pharmaceutical Technologies, announced today that Joseph (Joe) Del Buono has joined the Company as Vice President, Finance and Chief Financial Officer. He
August 26, 2015 13:30
Brazil’s A.C.Camargo Cancer Center Adopts Masimo SpHb for Noninvasive and Continuous Hemoglobin Monitoring
Masimo (www.masimo.co.uk) (NASDAQ: MASI) announced today that A.C.Camargo Cancer Center (Cancer Center, http://goo.gl/tHiUjA) in Sao Paulo, Brazil has installed Masimo’s noninvasive and continuous hem
August 25, 2015 17:40
FDA and EMA accept regulatory applications for Boehringer Ingelheim’s Giotrif® / Gilotrif® (afatinib) for treatment of advanced squamous cell carcinoma of the lung
Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted filing applications for afatinib for the treatment of p
August 25, 2015 14:25
ReSound Announces Expanded Android Compatibility with the ReSound Smart App for Smart Hearing Aid Wearers
ReSound®, a leader in innovative hearing technologies, announced today that it has expanded the number of Android devices compatible with the ReSound portfolio of Smart Hearing™ aids via the ReSound S
August 21, 2015 18:10
Takeda Announces European Medicines Agency Acceptance of Ixazomib’s Marketing Authorization Application for Patients with Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502, http://goo.gl/eX9kbP) today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for ixazomib
August 21, 2015 09:45
Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events
Boehringer Ingelheim and Eli Lilly and Company today announced positive top-line results from EMPA-REG OUTCOME®. This is a long-term clinical trial investigating cardiovascular (CV) outcomes for Jardi
August 19, 2015 17:20
CHMP recommends label update for Giotrif® with addition of data demonstrating overall survival benefit for patients with EGFR mutation-positive lung cancer
Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for an update to the European l
August 17, 2015 17:05
New data show Spiolto Respimat provides meaningful quality of life improvements in COPD
Boehringer Ingelheim today announced the publication of new data from the Phase IIIb OTEMTO® 1&2 trials (NCT01964352 (https://goo.gl/SvaXth)/NCT02006732 (https://goo.gl/F7UiIQ)), which show Spiolto® R
August 06, 2015 23:00
Chiltern Announces Agreement to Acquire Theorem Clinical Research
Chiltern (www.chiltern.com), a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research (www.theoremclinical.com), another
August 05, 2015 17:15
The Patient Safety Movement Foundation Names the Top 3 Healthcare Institutions that Demonstrated the Most Lives Saved
The Patient Safety Movement Foundation (http://patientsafetymovement.org) announced the winners of the top three healthcare institutions that demonstrated the most lives saved through their commitment
July 29, 2015 12:10
Boehringer Ingelheim enters into an exclusive license agreement with Hanmi Pharmaceutical to develop 3rd generation EGFR targeted therapy in lung cancer
Boehringer Ingelheim and Hanmi Pharmaceutical Co. Ltd today announced an exclusive license and collaboration agreement for the development and global commercialisation rights, except South Korea, Chin
July 28, 2015 11:30
European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted an accelerated asses
July 27, 2015 13:50
Panasonic Showcases Its Innovative Medical IT Solutions Brought to Life by Medicom @ International Modern Hospital Show 2015
Panasonic Healthcare Co., Ltd. (hereafter “Panasonic”) took part in the International Modern Hospital Show 2015, which was held from July 15 to 17, 2015 at the Tokyo Big Sight. Under the theme, “A new
July 24, 2015 10:55
Panasonic Autonomous Delivery Robots - HOSPI - Aid Hospital Operations at Changi General Hospital in Singapore
In line with the country’s goal of becoming a Smart Nation, Panasonic System Solutions Asia Pacific (PSSAP) and Changi General Hospital (CGH) are implementing assistive robotics technology to improve
25 per page50 per page75 per page100 per page